|
The
Twentieth Annual Malcolm T. MacEachern Symposium
And The 60th Anniversary Celebration
“Revolutionizing Tomorrow’s
Healthcare Delivery from
Technological, Scientific and Quality Improvements Today”
We are
in the midst of a revolution in healthcare … and it’s
happening on several fronts, in the life sciences, in pharma
and in innovative new devices and procedures, health systems
and in the newly empowered healthcare consumer. New technologies
have changed the ways in which we communicate, both in our
public and private lives. Cell phones, pagers, the computer,
e-mail and the internet can increase our productivity by making
us more accessible and information more readily available.
Technological advances are also aiding in new discoveries
in the life sciences – especially pharmaceuticals, biotech,
new devices and diagnostics, and genomics.
This year’s
MacEachern Symposium will explore those frontiers and their
implications for a lot of forces in the healthcare equation,
those hazy areas where these forces collide and where the
rules and economics are being worked out such as, how these
changes will be funded and what they will mean to the established
players. Things are moving at lightening speed, but what does
this mean for the healthcare system and for the many constituencies
within the healthcare framework. We have asked many leaders
of these constituencies to join us in discussing how they
see healthcare’s future taking shape.
To start
our 60th Anniversary program, we have asked Michael Sachs
back to prognosticate and to explain what changes technology
will have down the line and what disruptions they will make.
Mr. Sachs previously gave the MacEachern address in 2001.
Michael
A. Sachs, Chairman and Founders of SG-2, LLC is a
noted health care industry strategist and visionary. SG-2,
LLC analyzes the impact of changes in the business and technology
of health care. Its clients range from national health care
systems to leading academic research institutions, from health
plans to medical product suppliers. SG-2 developed The Edge,
the first and pre-eminent membership service to examine the
significance of new technology for the delivery and economics
of health care services.
Prior
to founding SG-2, Michael was the Chairman and Founder of
Sachs Group, which is now part of Solucient, LLC. Sachs Group,
founded in 1984, provided health care planning and marketing
data to over 1,000 institutions nationwide. Its market-forecasting
tools and target-marketing solutions were recognized as being
the most analytically sound and practical in the industry.
Prior
to forming Sachs Group, Michael was a consultant with Ernst
and Whinney and A.T. Kearney. He served on the management
team of Hurley Medical Center in Flint, Michigan. He earned
a BA in Science and a MSPH in Health Management from the University
of Missouri-Columbia. His health care career began in the
Emergency Department of the University of Missouri Medical
Center.
A
frequent lecturer on the future of health care and the impact
of changes on the delivery of care, Michael has presented
to executive teams, boards of trustees, industry groups and
physicians across the U.S. and abroad. He has contributed
articles to journals and magazines and co-authored books and
periodicals.
28th
Malcolm T. MacEachern Memorial Address
Thomas
A. Scully is the Administrator, Centers for Medicare
& Medicaid Services in the U.S. Department of Health and
Human Services. Mr. Scully was confirmed by the United States
Senate and was sworn in as the Administrator of the Centers
for Medicare & Medicaid Services (CMS) in May, 2001. As
the Administrator of CMS, Tom serves as CEO of the largest
health insurance organization in the world. CMS is responsible
for the management of Medicare, Medicaid, the State Children’s
Health Insurance Program and other national healthcare initiatives.
CMS has the second-largest budget outlay of the federal government.
The organization is directly responsible for $1 out of every
$3 spent on healthcare in the United States. The organization
insures approximately 25 percent of the U.S. population –
more than 70 million beneficiaries – including the elderly,
disabled and some of the lowest income individuals in the
country. CMS processes more than 1 billion claims each year
and it contracts with approximately 1 million providers.
Prior
to assuming responsibility as CMS Administrator, Tom served
as President and Chief Executive Officer of the Federation
of American Hospitals, the trade association representing
the nation’s 1700 privately-owned and managed community
hospitals and health systems from January, 1995 to May, 2001.
Previously,
Scully was a partner in the Washington, D.C., law firm of
Patton Boggs, LLP. His practice focused on regulatory and
legislative work in health care. Before joining the law firm,
Scully worked at the White House as Deputy Assistant to the
President and Counselor to the Director of the Office of Management
and Budget (OMB) from 1992-93, and as Associate Director of
OMB for Human Resources, Veterans and Labor from 1989-92.
In these positions, he oversaw the fiscal policy and regulatory
review of the Departments of Health and Human Services, Education,
Labor and Veterans Affairs. He also advised President Bush
on health care policy, Medicare and Medicaid payment reform.
In 1988,
Mr. Scully served on the communications staff of the Bush-Quayle
campaign and as Deputy Director of Congressional Affairs for
the President-Elect’s transition team. Mr. Scully holds
a Juris Doctor degree from Catholic University and a Bachelor’s
degree from the University of Virginia.
Following
Mr. Scully, we are delighted to welcome back to the podium
another previous MacEachern lecturer, Leonard Schaeffer, who
gave the Address in 1995.
Leonard
D. Schaeffer is Chairman and Chief Executive Officer
of WellPoint, one of the nation’s largest publicly traded
health care companies. WellPoint serves more than 13 million
medical members and more than 49 million specialty members.
WellPoint’s 2002 revenues were $17.3 billion.
Mr. Schaeffer
joined WellPoint’s predecessor, Blue Cross of California
in 1986 as President and CEO. He managed the turnaround of
Blue Cross of California and the transition to WellPoint,
which is now one of the nation’s most recognized and
respected health insurance companies.
Additionally,
Mr. Schaeffer led the recapitalization of WellPoint in 1996,
resulting in the creation of America’s sixth largest
philanthropy with a current endowment of more than $4 billion.
WellPoint subsequently increased the value of The Missouri
Foundation for Health to nearly $1 billion and endowed a Georgia-based
independent charitable foundation with $113.8 million to provide
health care services to underserved Georgians.
Previously,
Mr. Schaeffer was an executive of Citibank, Group Health,
Inc. of Minnesota, and the Student Loan Marketing Association.
Under President Carter, he was the administrator of the Health
Care Financing Administration (HCFA) in the U.S. Department
of Health Education and Welfare (now known as the Department
of Health and Human Services). Mr. Schaeffer directed the
Bureau of the Budget for the State of Illinois and also served
as chairman of the Illinois Capital Development Board and
Deputy Director for Management, Illinois Department of Mental
Health and Developmental Disabilities.
We will
continue following our luncheon with a group of key figures
who impact healthcare in a variety of critical ways.
Helen
Darling
Helen
Darling is President of the Washington Business Group on Health
(WBGH), the nation’s only non-profit organization devoted
exclusively to providing practical solutions to its members’
most important health care problems and representing large
employers’ perspective on national health policy issues.
Its 175 members represent more than 40 million employees,
retirees and their dependents.
As President
of the Business Group, Darling was named one of the “100
Most Powerful People in Health Care in 2003,” by Modern
Healthcare. WBGH fosters innovative health benefits decision
making among corporate purchasers and helps them share with
each other best practices and new solutions to their business
problems. A Capitol Hill veteran, Darling works with Congress
to advance the understanding of corporate health care issues.
She is also President of the Institute on Health Care Costs
and Solutions, an organization within WBGH, founded to focus
entirely on solutions to the health care cost crisis from
a business perspective.
Prior
to joining the Business Group, Darling served as Senior Consultant,
Group Benefits and Health Care for Watson Wyatt Worldwide.
Earlier, for six years, she directed health benefits purchasing
for 55,000 employees and retirees at Xerox Corporation. Darling
worked in the US Senate as advisor to Senator David Durenberger,
the ranking Republican on the Health Subcommittee of the Senate
Finance Committee. Darling received her master’s degree
in Demography/Sociology and her bachelor’s of science
degree in History/English, cum laude, from the University
of Memphis.
Bruce
E. Bradley is the Director, Health Plan Strategy
and Public Policy for Health Care Initiatives for the General
Motors Corporation. He is responsible for health care related
strategy and public policy, with a focus on quality measurement
and improvement, consumer engagement and cost effectiveness.
Bradley
joined GM in June, 1996. Prior to that, he spent five years
as Corporate Manager, Managed Care for GTE Corporation and
nearly 20 years in health plan and HMO management, including
10 years as President and CEO of a large staff model HMO.
He also co-founded the HMO Group, a national corporation of
15 non-profit, independent group practice HMOs, and the HMO
Group Insurance Co., Ltd.
Bradley
has gained broad recognition for his work in achieving health
plan quality improvement and for his efforts in developing
the Health Employer Data and Information Set (HEDIS) measurements
and processes. He is a board member of the National Quality
Forum, a member, past chair and co-founder of the Leapfrog
Group Board, a member of the board of FACCT, and a past board
member of The Academy for Health Services Research and Policy.
A native
of Pelham, N.Y., Bradley holds a bachelor’s degree in
psychology from Yale University and an MBA in health care
administration from the Wharton School at the University of
Pennsylvania.
Steven
Lazarus is a Managing Director for ARCH Venture Partners
and has managed entrepreneurial operations during his career.
He has played a key role in the formation and initial funding
round of a wide range of companies in the following areas:
biotechnology, pharmaceuticals, informatics, medical instrumentation,
software, and telecommunications.
From 1986
to 1994, Mr. Lazarus served as President and CEO of ARCH Development
Corporation and Associate Dean of the Graduate School of Business
of The University of Chicago.
Prior
to joining ARCH, Mr. Lazarus was Group Vice President of the
Health Care Services Group of Baxter Travenol Laboratories,
Inc., now Baxter Healthcare, Inc. During his 13 years at Baxter,
he held various positions including Senior Vice President
for Technology, which included manufacturing, materials management,
research and development, and engineering.
From 1972
to 1974, Mr. Lazarus served in Washington, D.C. as Deputy
Assistant Secretary of Commerce for East-West Trade and was
the founder and first director of the Bureau of East-West
Trade. He is a 21-year veteran of the U.S. Navy, retiring
with the rank of Captain in 1973.
Mr. Lazarus
is a director of Amgen Corp. (AMGN), Primark Corp. (PMK),
First Consulting Group, Inc. (FCGI), and R2 Technology, Inc.
He is also a Director of the National Venture Capital Association,
and the National Association of Corporate Directors.
He completed
his M.B.A. with high distinction at the Harvard Graduate School
of Business Administration and received a B.S. with honors
from Dartmouth College.
|